In the early development of atherosclerotic plaque, monocytes are recruited to the arterial intima where they accumulate lipid and become foam cells. The recently described murine chemotactic S100 protein, CP-10, may Mac-i. The initial events of monocyte recruitment and adhesion to the vessel wall may be important in macrophage foam cell development, and CP-10 or related S100 proteins may contribute to the early inflammatory events of atherogenesis by stimulating these events. (J. Clin. Invest. 1995Invest. . 95:1957Invest. -1965
Introduction
The pathogenesis of atherosclerosis is a chronic process which develops within a complex inflammatory and hyperlipidemic Receivedfor publication I June 1994 and in revisedform 9 January 1995. environment ( 1) . Although its etiology is unknown, the early recruitment of monocytes to the arterial intima and their subsequent accumulation of modified LDL are well documented (2) . Monocyte recruitment is highly regulated and is influenced by a variety of chemotactic factors such as FMLP (3) , macrophage colony-stimulating factor (M-CSF),' (4) or monocyte chemoattractant protein-i (5 ) , and the expression of adhesion molecules (6). Our laboratory described a novel murine chemotactic mediator termed CP-10 (chemotactic protein of molecular mass 10.3 kD), an S100 protein with potent chemotactic activity for myeloid cells in vitro (7, 8) and in vivo (8, 9) . S100 proteins are characterized by two highly conserved calcium-binding domains separated by a highly divergent "hinge" region. The hinge region of CP-10 (CP-1042-55) contributes significantly to the chemotactic activity of the protein, measured using Boyden chamber assays (8) . In contrast to "classical" leukocyte chemotactic agents (FMLP, CSa, 1L-8), which elicit relatively weak and transient (2-6 h) inflammatory reactions in vivo (10, 11) , CP-I0 elicits a more sustained (4-24 h) inflammatory response (8, 9) .
Adhesion molecules on both leukocytes and endothelial cells are important in mediating leukocyte attachment and accumulation at inflammatory foci. The leukocyte #I and 12 integrins play a critical role in mediating strong, sustained adhesion (6) and their engagement may influence leukocyte activation and effector functions (12, 13) . Mac-i (CDllb/CD18, aMJ32) and lymphocyte function-associated antigen-i (LFA-1, CDlIa/ CD18, a&2) share a common 16 chain (CD18) whereas very late activation antigen-4 (VLA-4, CD49d/CD29, a4381) belongs to the ,16 family. Mac-I recognizes a diverse array of ligands involved in the inflammatory process. These include complement protein fragment C3bi, fibrinogen, factor X, and denatured proteins (13, 14) . The (15, 16) .
Macrophages in the subendothelial space accumulate cholesteryl esters (CEs) to become foam cells ( 1, 2) . The scavenger receptor (SR) mediates uptake of modified LDL such as oxidized LDL and acetylated LDL (AcLDL) (17) and may be involved in macrophage foam cell formation in vivo (18) . It may also mediate other potentially important physiological functions including binding of LPS (19) and adhesion (20) .
Unlike the LDL receptor it is not downregulated in response to high levels of intracellular cholesterol (21) . SR mRNA expression in macrophages in human atherosclerotic lesions is not uniform ( 18) , and its activity may be dependent on macrophage maturation (22, 23) . Functional expression is increased by M-CSF (24, 25) whereas TGFf31 (26), IFNy (27, 28) , and TNFa (29) Analysis of intracellular lipid HPLC. Cells were washed 3 times with cold PBS, lysed with 0.6 ml of 0.2 M NaOH and intracellular lipid extracted from 0.3 to 0.4 ml of lysate analyzed for cholesterol, CEs, or lipid oxidation products by HPLC as described (32).
Oil red 0 staining. Cell suspensions were cytocentrifuged onto glass slides and stained with oil red 0 (34). Alternatively, cells cultured on sterile glass coverslips in tissue culture wells under the experimental conditions specified were washed twice with cold PBS before fixing and staining. Counterstain was Gill's hematoxylin (Sigma Immunochemicals).
Flow cytometry
Resident or elicited peritoneal cells (106 cells) were suspended in 20% heat-inactivated normal mouse serum/phenol red-free HBSS to block nonspecific binding, then incubated with the primary or isotype-matched control antibody in phenol red-free HBSS/5% heat-inactivated normal mouse serum/0.05% sodium azide for 60 min at 4°C. Saturating concentrations of primary antibodies were used and hybridoma supernatants were undiluted. Cells were washed twice, incubated with F(ab')2 goat anti-rat Ig-R-phycoerythrin for 30 min at 4°C, and after a final wash were fixed with 1% paraformaldehyde/PBS and analyzed by flow cytometry using the EPICs Profile II system (Coulter Corp., Hialeah, FL). Intraperitoneal injection of AcLDL caused macrophage CE accumulation which became significant only after 48 h (P = 0.002 compared with control mice). When AcLDL was preceded by CP-104255, macrophage CE accumulation markedly increased. This was 2.4 times that of cells from control mice injected with diluent and AcLDL only (P = 0.01) after 48 h, and 3.7 times that of corresponding cells harvested after 24 h (P = 0.01). The CE fraction of the total cholesterol increased from 28±2.6% in cells from AcLDL-injected mice to 38±3.3% in cells from mice injected with both CP-104255 and AcLDL after 24 h (P = 0.04), and from 47±4.7 to 59±2.8% in corresponding groups harvested after 48 h (P = 0.08). Changes in free cholesterol followed a similar pattern, but were less marked than changes in CE content. (Fig. 1 B) . Macrophage lipid accumulation in vitro. Resident cells cultured with CP-104255 and AcLDL had only minor, statistically insignificant increased CE accumulation (Fig. 2) . In contrast, monocyte/macrophages elicited by CP-1042-55 accumulated markedly increased CEs compared with control (diluent-elicited) cells when cultured with AcLDL in vitro (Fig. 3 A) . Cells cultured without AcLDL contained predominantly free cholesterol with only low levels of CEs. Control cells cultured with AcLDL contained significant levels of CE, whereas 24-h CP-104255-elicited macrophages had even more CE (1.7-fold, P = 0.005). CE accumulation in both control and 24-h CP-104255-elicited macrophages was completely inhibited by fucoidin (50 Ag/ml, not shown), consistent with SR involvement in AcLDL uptake. The CE fraction of total cholesterol of diluent-or CP-1042-55-elicited macrophages cultured with AcLDL increased from 55±5.8 to 70±4.5% (P = 0.02) and from 59±4.4 to 78±0.8% (P = 0.009) in macrophages harvested at 8 and 24 h, respectively. In contrast, no significant differences in either total cholesterol (from 85.8±5.0 to 90.4±5.3 pug/mg protein) or CE fraction (from 56±3.0 to 60±3.3%) were evident in macrophages harvested after 48 h.
A single i.p. injection of M-CSF (2 4tg) elicited a weak response at 24 h (stimulation index 1.3±0.3) and comprised predominantly macrophages (8±1% PMNs, 65±2% macrophages). To obtain an inflammatory population containing similar proportions of cell types to that 24 h after CP-1042-55 injection, cells were harvested 16 h after TG injection (stimulation index 8.4±2.3, 40±6% PMNs, 43±7% macrophages). CE accumulation did not increase significantly in M-CSF-elicited macrophages cultured with AcLDL (Fig. 3 B) , whereas 16-h TG-elicited macrophages accumulated substantially less CE (P < 0.001) than control cells (Fig. 3 C) . Cells harvested 72 h after TG injection (80±2% macrophages) also loaded less AcLDL (not shown).
Macrophages elicited 24 h after CP-104255 injection and incubated with oxidized LDL accumulated increased free and esterified cholesterol compared with diluent-elicited controls (not shown). 7-Ketocholesterol, the predominant oxysterol in oxidized LDL, increased 1.5-fold from 7.1±0.9 IHg/mg protein in diluent-elicited cells to 10.7±1.1 /ug/mg protein in CP-1042-55-elicited cells. CE content ( 19+3.8% of total cholesterol) in CP-104255-elicited oxidized LDL-loaded macrophages was -51% less than that of AcLDL-loaded macrophages. This was consistent with published observations of the lower CE content in oxidized LDL (32) and oxidized LDL-loaded macrophages (35) .
Oil red 0 staining. Oil red 0 staining confirmed the differences in AcLDL loading observed with HPLC analysis, for macrophages loaded in vivo (Fig. 4 , A-C) and in vitro (Fig.  4, D-F) . Macrophages from mice injected with saline and AcLDL only (Fig. 4 B) , and from mice injected with both CP-1042-55 and AcLDL (Fig. 4 C) , appeared larger than those from control mice (Fig. 4 A) . Although lipid staining within macrophages was heterogeneous, there was a marked increase in both the number of cells containing lipid and the lipid content of each cell in CP-1042-55-elicited populations loaded with AcLDL both in vivo and in vitro, compared with diluent-elicited controls.
Analysis of cellular CE composition. Flow cytometric analysis ofscavenger receptor and , / integrin expression on resident and elicited macrophages. Subpopulations within newly recruited myeloid cell populations were identified using mAbs against Mac-l (3), F4/80 (36) , and mouse granulocyte-specific antigen (37 (Table III) .
Effect ofadhesion on macrophage lipid accumulation. Macrophage CE accumulation was profoundly affected by adhesion. CP-1042-55-elicited macrophages incubated with AcLDL for 24 h in adherent conditions had significantly more CE (1.6-to 2-fold, P < 0.001) than cells cultured in nonadherent conditions (Fig. 5) . Even though resident and TG-elicited macrophages accumulated proportionally less CE than CP-104255-elicited macrophages, adherent culture also significantly increased CE levels by approximately twofold in these cells (not shown).
To investigate the role of Mac-i binding in macrophage lipid accumulation and in the absence of a neutralizing antibody to murine Mac-i, we used an anti-Mac-I mAb (MI/70) which binds to the a subunit (CD l lb) and induces phenotypic changes which correlate with activation of resident mouse peritoneal macrophages (38) . Cells elicited by CP-104255 after 24 (17, 22) , and lipid loading in vitro may be modulated by various cytokines (24, 26, 28, 29) . Human peripheral blood-derived monocytes differentiated in vitro (22, 23) , macrophage cell lines (26) , and murine resident peritoneal (17) (Table I) . CP-10 elicits a sustained inflammatory response with cellular characteristics reminiscent of a delayed-type hypersensitivity reaction (8) . Devery et al. (9) characterized the acute response to CP-1042s55 which peaked 8 h after i.p. injection and consisted mainly of PMNs. Table I shows that the early PMN-rich infiltrate was followed by a population containing proportionally larger numbers of monocyte/macrophages after 24 h when monocyte numbers increased some sixfold. Although CP-10 did not directly promote AcLDL loading of resident macrophages (Fig. 2) , CP-104255-elicited macrophages accumulated significantly increased levels of CEs, a reflection of lipid loading (41) , in response to AcLDL both in vivo (2.4-fold; Fig. 1 A) and in vitro (1.7-fold; Fig. 3 ). Macrophages resembled foam cells both morphologically (Fig. 4, C and F) and on the basis of their lipid content (CE > 50% of total cholesterol [41] ). In accordance with reports that resident (17) or TG-elicited (40) macrophages do not load with LDL in vitro, native LDL did not accumulate as CE either in resident or CP-104255-elicited macrophages. FMLP was used in an attempt to compare the responses provoked by CP-1042-55 with a classical chemoattractant. This agent failed to recruit significant numbers of monocyte/macrophages and only minor increases in lipid loading were evident in vivo (Fig. 1 B) . The cell population elicited 16 h after TG injection had a similar composition to that elicited by CP-104255 after 24 h but AcLDL loading in vitro was decreased compared with resident cells (Fig. 3 C) . These results suggest that the increased CE accumulation in response to AcLDL observed with CP-1042-55-elicited macrophages was not (Table  III) , and its involvement in AcLDL uptake was confirmed by inhibition of CE accumulation using fucoidin. Furthermore, TGand M-CSF-elicited macrophages had levels of SR similar to those on resident cells (Table III) and did not accumulate increased CE (Fig. 3, B (9) , whereas it fails to directly upregulate Mac-I expression in vitro (Cornish, C. J., J. Devery, P. Poronik, D. I. Cook, and C. L. Geczy, manuscript submitted for publication). Despite potent chemotactic activity in vivo and in vitro, the lack of a direct effect characteristic of classical chemoattractants (46) on some parameters of cellular activation is shared by other "pure" chemoattractants, e.g., TGF,61 (46, 47) . The possibility that the affinity of Mac-I may be directly altered by CP-10, as reported for other integrins (48) , is currently being investigated. Our results suggest that the sustained and marked leukocyte recruitment elicited by CP-lO may be mediated by the production of other cytokines from cells within the local environment and these may contribute to and potentiate the inflammatory response.
Adhesion significantly increased macrophage CE accumulation by approximately twofold in CP-104255-elicited (Fig. 5) , resident, and TG-elicited macrophages (not shown), which were all Mac-i bright (Table III) . Apart from contributing to the initiation of macrophage differentiation (49) , which in turn is associated with increased SR activity (22, 23) , the process of adhesion via integrin engagement may result in transduction of cellular signals that enhance leukocyte activation and effector functions (12, 13) . Ligation of Mac-i with a mAb which activates some functions of murine peritoneal macrophages (38) increased AcLDL loading in CP-104255-elicited macrophages cultured in nonadherent conditions to a similar degree as when adherent culture was used (Fig. 5) . Like the SR (20) , Mac-i can mediate both adhesion and endocytosis (14) . Although M-CSF-, TG-, and 48-h CP-1042-55-elicited monocyte/macrophages were also Mac-I bright (Table III) , levels of CEs in response to AcLDL were not significantly enhanced (Fig. 3) , indicating that AcLDL uptake exclusively via Mac-I is unlikely to be a major contributing factor to macrophage lipid loading. Optimum loading and CE accumulation may require upregulation of both SR and Mac-I expression and/or affinity, in association with an "activated" cell status; and the process of adhesion via Mac-i ligation may result in further cell activation or potentiation of effector functions. When monocytes are recruited to the developing atherosclerotic lesion, Mac-1 binding to its counterreceptor intercellular adhesion molecule-I on en-dothelial cells (15) may initiate foam cell formation by stimulating lipid loading even before the cells transgress the endothelial barrier, especially in the setting of hypercholesterolemia.
CP-10 has 58% amino acid identity with the human S100 protein termed migration inhibitory factor-related protein-8 (MRP-8) (8) . Like MRP-8 (50), CP-10 is expressed in bone marrow and circulating myeloid cells but not in resident tissue macrophages (51), whereas both are expressed by myeloid cells at sites of inflammation (52) (Kocher, M., personal communication). MRP-8 has been identified in human atherosclerotic plaque (53, 54) as part of the LI antigen complex recognized by the mAb MAC 387 (55), suggesting a potential role for this or related S100 proteins as inflammatory mediators in this setting. CP-10 (9) and MRP-8 (56) associate with the vasculature adjacent to marginating leukocytes within inflammatory sites and are possibly secreted onto the associated endothelium as the cells diapedese. In the inflammatory and hypercholesterolemic environment of the atherosclerotic plaque, secreted CP-10 may act in an autocrine or paracrine fashion which, together with other monocyte chemoattractants (e.g., monocyte chemoattractant protein-1 [5] , M-CSF [4] , TGF31 [47] , and oxidized LDL [57] ), may form part of the amplification mechanism required for sustained recruitment of mononuclear cells. As with any factor administered in vivo, one cannot definitively assign the observed changes in cell function to the direct action of the factor. Although it is likely that secondary mediators are responsible for some of the in vivo effects described here, CP-10 or related S100 proteins may have a role in stimulating leukocyte recruitment and in generating an inflammatory environment which favors macrophage lipid loading and foam cell formation in the developing atherosclerotic lesion.
